These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 32045384)
1. Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function. Sarhan D; Wang J; Sunil Arvindam U; Hallstrom C; Verneris MR; Grzywacz B; Warlick E; Blazar BR; Miller JS JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32045384 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303 [TBL] [Abstract][Full Text] [Related]
3. The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes. Wang Z; Tang X; Xu W; Cao Z; Sun L; Li W; Li Q; Zou P; Zhao Z PLoS One; 2013; 8(3):e57470. PubMed ID: 23469196 [TBL] [Abstract][Full Text] [Related]
4. The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome. Zheng L; Zhang L; Guo Y; Xu X; Liu Z; Yan Z; Fu R Front Immunol; 2022; 13():1078421. PubMed ID: 36569863 [TBL] [Abstract][Full Text] [Related]
5. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma. Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504 [TBL] [Abstract][Full Text] [Related]
6. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes. Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014 [TBL] [Abstract][Full Text] [Related]
7. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion. Roversi FM; Lopes MR; Machado-Neto JA; Longhini AL; Duarte Ada S; Baratti MO; Palodetto B; Corrocher FA; Pericole FV; Campos Pde M; Favaro P; Traina F; Saad ST Stem Cells Dev; 2014 May; 23(10):1109-20. PubMed ID: 24410667 [TBL] [Abstract][Full Text] [Related]
8. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome. Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor. Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy. Poon Z; Dighe N; Venkatesan SS; Cheung AMS; Fan X; Bari S; Hota M; Ghosh S; Hwang WYK Leukemia; 2019 Jun; 33(6):1487-1500. PubMed ID: 30575819 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes. Kim M; Hwang S; Park K; Kim SY; Lee YK; Lee DS PLoS One; 2015; 10(3):e0120602. PubMed ID: 25803272 [TBL] [Abstract][Full Text] [Related]
12. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway. Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415 [TBL] [Abstract][Full Text] [Related]
13. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes. Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017 [TBL] [Abstract][Full Text] [Related]
14. Identification of neuroblastoma cell lines with uncommon TAZ Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207 [TBL] [Abstract][Full Text] [Related]
16. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells. Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Pleyer L; Valent P; Greil R Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944 [TBL] [Abstract][Full Text] [Related]
18. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis. Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537 [TBL] [Abstract][Full Text] [Related]
19. [Immuno-suppressive effects on T cells mediated by mesenchymal stem cells from patients with myelodysplastic syndrome]. Liu LH; Chen H; Chen B; Sun Z; Ye LP; Shi B; Jin JG; Zhao CH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):299-304. PubMed ID: 18426653 [TBL] [Abstract][Full Text] [Related]
20. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]